Genomic test to breast cancer patients

Unilabs, a supplier of cellular pathology services in the UK, has announced that patients will now have access to the Oncotype DX breast cancer test at partner clinics and hospitals, including the Harley Street Breast Clinic in London. Developed by Genomic Health, the Oncotype DX test is a genomic assay that enables doctors and their patients with early-stage oestrogen receptor-positive invasive breast cancer to make more informed, individualised treatment decisions.